U.S. Markets close in 2 hrs 36 mins

Cancer Genetics, Inc. (CGIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4900-0.0800 (-3.11%)
As of 1:21PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.5700
Open2.5000
Bid2.4700 x 800
Ask2.4900 x 800
Day's Range2.4300 - 2.5500
52 Week Range1.9200 - 10.3900
Volume158,307
Avg. Volume159,209
Market Cap10.146M
Beta (5Y Monthly)2.77
PE Ratio (TTM)N/A
EPS (TTM)-2.0710
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – MVC, PTI, CGIX, STND
    GlobeNewswire

    Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – MVC, PTI, CGIX, STND

    NEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: MVC Capital, Inc. (NYSE: MVC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Barings BDC, Inc. Under the terms of the merger agreement, MVC Capital shareholders will receive 0.94024 shares of Barings BDC and $0.39492 in cash for each share of MVC Capital stock. If you are an MVC Capital shareholder, click here to learn more about your legal rights and options.Proteostasis Therapeutics, Inc. (NASDAQ: PTI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Yumanity Therapeutics. If you are a Proteostasis shareholder, click here to learn more about your legal rights and options.Cancer Genetics, Inc. (NASDAQ: CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer Genetics expected to own 22% of the common stock of the combined company. If you are a Cancer Genetics shareholder, click here to learn more about your legal rights and options.Standard AVB Financial Corp. (NASDAQ: STND) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Dollar Mutual Bancorp for $33.00 per share. If you are a Standard AVB shareholder, click here to learn more about your legal rights and options.Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.Attorney Advertising. Prior results do not guarantee a similar outcome.Contact Information: Halper Sadeh LLP Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 sadeh@halpersadeh.com zhalper@halpersadeh.com

  • Halper Sadeh LLP Announces it is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PNM, STND, CBMG, CGIX
    GlobeNewswire

    Halper Sadeh LLP Announces it is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PNM, STND, CBMG, CGIX

    NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: PNM Resources, Inc. (NYSE: PNM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Avangrid, Inc. for $50.30 in cash per share. If you are a PNM Resources shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/pnm-resources-inc-stock-merger-avangrid/.Standard AVB Financial Corp. (NASDAQ: STND) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Dollar Mutual Bancorp for $33.00 per share. If you are a Standard AVB shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/standard-avb-financial-corp-stnd-merger-stock-dollar-mutual/.Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. If you are a Cellular Biomedicine shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/cellular-biomedicine-group-inc-cbmg-stock-merger/.Cancer Genetics, Inc. (NASDAQ: CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer Genetics expected to own 22% of the common stock of the combined company. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/cancer-genetics-inc-cgix-stock-merger-stemonix/.Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.Attorney Advertising. Prior results do not guarantee a similar outcome.Contact Information: Halper Sadeh LLP Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 sadeh@halpersadeh.com zhalper@halpersadeh.com https://www.halpersadeh.com